Thiazolidinediones and the Risk of Lung, Prostate, and Colon Cancer in Patients With Diabetes

Peroxisome proliferator-activated receptor gamma (PPARgamma) mediates cell cycle arrest and adipocyte differentiation; has tumor suppressor activity in liposarcoma, lung, and prostate cancers; and suppresses colonic polyp formation in adenomatous polyposis coli (APC)min/+ mice. To assess the influen...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of clinical oncology 2007-04, Vol.25 (12), p.1476-1481
Hauptverfasser:	GOVINDARAJAN, Rangaswamy, RATNASINGHE, Luke, SIMMONS, Debra L, SIEGEL, Eric R, MIDATHADA, Madhu V, KIM, Lawrence, KIM, Peter, OWENS, Randall J, LANG, Nicholas P
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Age Distribution Aged Biological and medical sciences Causality Colonic Neoplasms - epidemiology Comorbidity Confidence Intervals Diabetes Mellitus, Type 2 - diagnosis Diabetes Mellitus, Type 2 - drug therapy Diabetes Mellitus, Type 2 - epidemiology Dose-Response Relationship, Drug Humans Incidence Lung Neoplasms - epidemiology Male Medical sciences Middle Aged Pneumology Probability Prognosis Prostatic Neoplasms - epidemiology Registries Retrospective Studies Risk Assessment Survival Analysis Thiazolidinediones - therapeutic use Tumors Tumors of the respiratory system and mediastinum
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!